23 reports

HIV/ AIDS, rheumatoid arthritis, hepatitis B and psychiatric disorders.

  • Chronic Pain
  • China
  • Demand
  • Bayer AG
  • Yunnan Baiyao Group Co., Ltd.

HIV/ AIDS, rheumatoid arthritis, hepatitis B and psychiatric disorders.

  • Chronic Pain
  • China
  • Bayer AG
  • Novartis AG
  • Pfizer Inc.

He is experienced in designing and executing operational research study on HIV/ AIDS services uptake among high risk groups (HRGs) in India.

  • Arthritis
  • Chronic Pain
  • United States
  • Forecast
  • ROBUST PIPELINE OF CANDIDATE DRUGS BEING DEVELOPED FOR A VARIETY OF CHRONIC CLINICAL CONDITIONS

WE OBSERVED THAT THERE ARE ## MOLECULES BEING DEVELOPED FOR THE MANAGEMENT OF NEUROPATHIC PAIN, WHICH IS CHARACTERISTIC OF FIBROMYALGIA, CANCER, DIABETES, HIV/ AIDS AND POST HERPETIC NEURALGIA.

  • Chronic Pain
  • North America
  • United States
  • Eli Lilly & Co.
  • Grunenthal GmbH

FOR HIV/ AIDS (PHASE III), ZORCELL FOR PSORIASIS (PHASE ## RemuneX™ is a trademark of Immune Response BioPharma ## Zorcell™ is a trademark of Immune Response BioPharma ## CrohnsVax™ is a trademark of Immune Response BioPharma ## ##.

  • Chronic Pain
  • North America
  • United States
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Chronic neuropathic pain is caused by injury or another disease. Some common causes may include

Some common causes may include: High alcohol intake Amputation (can result in phantom limb syndrome; a type of neuropathic pain) Injury to legs, hip or back Multiple sclerosis Diabetes Spinal surgery Herpes zoster infection, HIV/ AIDS CAUSE OF THE DISEASE Smoking Occupation Fem

  • Chronic Disease
  • Chronic Pain
  • Pathology

The drug candidate is filed for marketing authorization in the Republic of Senegal for HIV/ AIDS, cancer and as an immune booster.

  • Chronic Pain
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative

Government s initiative to deliver life-saving services and improve the lives of those living with HIV/ AIDS around the world.

  • Chronic Pain
  • Clinical Trial
  • Drug Development
  • United States
  • Sanofi S.A.
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Chronic Pain
  • Clinical Trial
  • Neurology
  • Pharmaceutical
  • Eli Lilly & Co.

The drug candidate is filed for marketing authorization in the Republic of Senegal for HIV/ AIDS, cancer and as an immune booster.

  • Chronic Pain
  • Pathology
  • Pharmaceutical
  • Therapy
  • Product Initiative
  • Target
  • 5. All the trials included are unique trials.

(Inactive) Neurologic AIDS Research Consortium ## Sep 2003 ## Aug 2003 ## Dec 2004 ## Mar 2005 ## ## ## ## Target Clinical Trial profile. ## Trial Title Official Title Trial Identifier Secondary ID(s) Therapy Area Indication(s) Trial Status Trial Phase Study Type Drug(s)/ Molecule(s)

  • Chronic Pain
  • Clinical Trial
  • Opioid
  • World
  • Pfizer Inc.

The prominent features of this report are - ##.

  • Chronic Pain
  • Clinical Trial
  • World
  • Product Initiative
  • Pfizer Inc.
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

(Inactive) Neurologic AIDS Research Consortium ## Sep 2003 ## Aug 2003 ## Dec 2004 ## Mar 2005 ## ## ## ## Official Title Clinical Trial profile. ## Trial Title Official Title Trial Identifier Secondary ID(s) Therapy Area Indication(s) Trial Status Trial Phase Study Type Drug(s)/ Mo

  • Chronic Pain
  • Clinical Trial
  • Drug Development
  • Neurology
  • Pfizer Inc.
  • CLINICAL TRIAL PROFILE SNAPSHOTS

Boehringer Sohn AG & Co KG ## ## ## ## ## ## ## ## Amgen Inc ## ## ## ## ## ## ## ## Mylan NV ## ## ## ## ## ## ## ## Parexel International Corp ## ## ## ## ## ## ## ## Novartis AG ## ## ## ## ## ## ## ## Johnson & Johnson ## ## ## ## ## ## ## ## Bristol-My

  • Arthritis
  • Chronic Pain
  • Immunology
  • Monoclonal Antibody
  • Pfizer Inc.

Its product line includes chemicallysynthesized drugs and biological products in the areas of cancer, psychiatric disorders, cardiovascular disorders, diabetes, hepatitis B, HIV/ AIDS and rheumatoid arthritis.

  • Chronic Pain
  • Protein Therapy
  • Therapy
  • Product Initiative
  • ChemoCentryx, Inc.

Its products are used to treat multiple sclerosis, sepsis shock, HIV AIDS, rheumatoid arthritis, Crohn' s disease and psoriasis.

  • Chronic Pain
  • Neurological Disorder
  • Pathology
  • Therapy
  • Anavex Life Sciences Corp.

The prominent features of this report are - ##.

  • Chronic Pain
  • Endocrine Disease
  • World
  • Product Initiative
  • Pfizer Inc.
  • DIABETIC NEUROPATHIC PAIN - PIPELINE BY BRISTOL-MYERS SQUIBB COMPANY, H2 2016
  • BRISTOL-MYERS SQUIBB COMPANY

Its product line includes chemicallysynthesized drugs and biological products in the areas of cancer, psychiatric disorders, cardiovascular disorders, diabetes, hepatitis B, HIV/ AIDS and rheumatoid arthritis.

  • Chronic Pain
  • Therapy
  • United States
  • World
  • Product Initiative
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Chronic Pain
  • Clinical Trial
  • Drug Development
  • World
  • Product Initiative

The prominent features of this report are - ##.

  • Chronic Pain
  • Clinical Trial
  • Pharmaceutical
  • World
  • Product Initiative

The prominent features of this report are - ##.

  • Chronic Pain
  • Clinical Trial
  • Neurological Disorder
  • Pharmaceutical
  • World

It aims at exploring the cellular introduction of genetic elements as a treatment for HIV/ AIDS.

  • Chronic Pain
  • Monoclonal Antibody
  • Targeted Therapy
  • Therapy
  • United States

R& D Progress SMALL MOLECULE FOR HIV-## INFECTION Product Description Mechanism of Action Small molecule for HIV-## infection is under development.

  • Chronic Pain
  • Oncology
  • Research And Development
  • Therapy
  • Boehringer Ingelheim GmbH